Westover Capital Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $628K | Buy |
28,957
+16,674
| +136% | +$362K | 0.13% | 129 |
|
|
2025
Q1 | $298K | Sell |
12,283
-222
| -2% | -$5.38K | 0.07% | 194 |
|
|
2024
Q4 | $261K | Sell |
12,505
-270
| -2% | -$5.64K | 0.06% | 201 |
|
|
2024
Q3 | $254K | Sell |
12,775
-1,677
| -12% | -$33.3K | 0.05% | 215 |
|
|
2024
Q2 | $224K | Sell |
14,452
-18
| -0.1% | -$279 | 0.06% | 195 |
|
|
2024
Q1 | $231K | Sell |
14,470
-70,106
| -83% | -$1.12M | 0.07% | 165 |
|
|
2023
Q4 | $1.42M | Sell |
84,576
-942
| -1% | -$15.8K | 0.46% | 54 |
|
|
2023
Q3 | $1,000K | Sell |
85,518
-17,379
| -17% | -$203K | 0.36% | 68 |
|
|
2023
Q2 | $1.38M | Buy |
+102,897
| New | +$1.38M | 0.48% | 52 |
|